Snowball logo
logo
25K_logo

Karyopharm Therapeutics Inc

€4.70€0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
108.1209.8157.1146145.2145.2
COGS
2.7053.4025.2134.9426.0076.007
Gross Profit
105.4206.4151.9141.1139.2139.2
Operating Expenses & Income
Operating Income
(171.8)(98.27)(142.2)(129.5)(119.4)(119.4)
Total Operating Expenses
279.9308.1299.3275.6264.7264.7
R&D Expenses
150.8160.8148.7138.8143.2143.2
Selling General & Admin Expenses
126.4143.8145.4131.9115.4115.4
Earnings from Continuing Operations
Interest Expense
(27.14)(26.05)(25)(23.82)(37.42)(37.42)
Interest Income
2.820.5822.35910.947.47.4
Income Tax Expense
0.3090.2680.369---
Net Income
Net Income
(196.3)(124.1)(165.3)(143.1)(76.42)(76.42)
Supplemental
EBIT
(171.8)(98.27)(129)---
EBITDA
(167.9)(97.77)(139.9)---
In millions of EUR, except % and values per 1 share